With all of the discussion in the medical community and beyond regarding new drug approvals for diabetes, it is easy to forget that many of these drugs are not approved for children and adolescents. Silva A. Arslanian, MD, Professor of Pediatrics, University of Pittsburgh School of Medicine, explains why this is and describes the treatment options available to pediatricans treating diabetes and one possibe medication which may be studied in the future.
More videos with Dr. Arslanian:
Silva A. Arslanian, MD, is Chief, Weight Management and Wellness Center; Director, Pediatric Clinical and Translational Research Center; UPMC Richard L. Day Endowed Chair in Pediatrics; and Professor of Pediatrics, University of Pittsburgh School of Medicine. She attended medical school at the American University of Beirut School of Medicine, Beirut, Lebanon; did her residency at the American University Hospital of Beirut, Beirut, Lebanon; and fellowship at Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA.